C46H54N11O6P — CID 165124717
4-[5-[4-[4-[[4-(2-dimethylphosphorylanilino)-5-methylpyrimidin-2-yl]amino]-5-methoxy-2-(1-methylpyrazol-4-yl)phenyl]piperazin-1-yl]pentylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione (PubChem CID 165124717) has the molecular formula C46H54N11O6P and a molecular weight of 887.98 g/mol. Its IUPAC name is 4-[5-[4-[4-[[4-(2-dimethylphosphorylanilino)-5-methylpyrimidin-2-yl]amino]-5-methoxy-2-(1-methylpyrazol-4-yl)phenyl]piperazin-1-yl]pentylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione.
| Compound Name | 4-[5-[4-[4-[[4-(2-dimethylphosphorylanilino)-5-methylpyrimidin-2-yl]amino]-5-methoxy-2-(1-methylpyrazol-4-yl)phenyl]piperazin-1-yl]pentylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione |
|---|---|
| PubChem CID | 165124717 |
| Molecular Formula | C46H54N11O6P |
| Molecular Weight | 887.98 g/mol |
| Exact Mass | 887.40 |
| IUPAC Name | 4-[5-[4-[4-[[4-(2-dimethylphosphorylanilino)-5-methylpyrimidin-2-yl]amino]-5-methoxy-2-(1-methylpyrazol-4-yl)phenyl]piperazin-1-yl]pentylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione |
| SMILES | COc1cc(N2CCN(CCCCCNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)c(-c2cnn(C)c2)cc1Nc1ncc(C)c(Nc2ccccc2P(C)(C)=O)n1 |
| InChI | InChI=1S/C46H54N11O6P/c1-29-26-48-46(53-42(29)50-33-13-7-8-15-39(33)64(4,5)62)51-35-24-32(30-27-49-54(2)28-30)37(25-38(35)63-3)56-22-20-55(21-23-56)19-10-6-9-18-47-34-14-11-12-31-41(34)45(61)57(44(31)60)36-16-17-40(58)52-43(36)59/h7-8,11-15,24-28,36,47H,6,9-10,16-23H2,1-5H3,(H,52,58,59)(H2,48,50,51,53) |
| InChIKey | SDZVOGPDPHKPLC-UHFFFAOYSA-N |
| XLogP | 5.73 |
| TPSA | 196.02 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 64 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 887.98 |
| LogP ≤ 5 | 5.73 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 15 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|